Consumption of cheese and milk and chronic diseases associated with obesity, friend or foe?;Consumo de queso y lácteos y enfermedades crónicas asociadas a obesidad, ¿amigo o enemigo?

Nutricion Hospitalaria

Volumn 32, Issue 1, 2015, Pages 61-68

  Agüero, Samuel Durán ^a   García, Jairo Torres ^b   Catalán, Julio Sanhueza ^c  

^a UNIVERSIDAD SAN SEBASTIÁN   (Chile)

^b UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Cardiovascular disease; Cheese; Dairy; Diabetes; Obesity

Indexed keywords

ANIMAL; CARDIOVASCULAR DISEASES; CHEESE; CHRONIC DISEASE; COMPLICATION; DAIRY PRODUCT; HEALTH SURVEY; HUMAN; MILK; OBESITY;

ANIMALS; CARDIOVASCULAR DISEASES; CHEESE; CHRONIC DISEASE; DAIRY PRODUCTS; HUMANS; MILK; OBESITY; PUBLIC HEALTH SURVEILLANCE;

EID: 84936746870     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2015.32.1.8982     Document Type: Article

References (117)

1. Van Staveren WA, de Groot LC, Burema J, de Graaf C. Energy balance and health in SENECA participants. Survey in Europe on Nutrition and the Elderly, a Concerted Action. Proc Nutr Soc. 1995; 54(3):617-29.
2. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011; 123(8):933- 44.
3. Law M, Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ. 1999; 318(7196):1471-6.
4. Lippi G, Franchini M, Favaloro EJ, Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". Semin Thromb Hemost. 2010; 36(1):59-70.
5. Wu JM, Hsieh TC. Resveratrol: a cardioprotective substance. Ann N Y Acad Sci. 2011; 1215:16-21.
6. Elisha B, Guebre-Egziabher F, Vidal H, Bastard JP, Laville M, Rabasa-Lhoret R. From French to Mediterranean diet: importance of the omega-6/omega-3 fatty acids ratio. World Rev Nutr Diet. 2011; 102:81-91.
7. Nadtochiy SM, Redman EK. Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition. 2011; 27(7-8):733-44.
8. Tabernero M, Venema K, Maathuis AJ, Saura-Calixto FD. Metabolite production during in vitro colonic fermentation of dietary fiber: analysis and comparison of two European diets. J Agric Food Chem. 2011; 59(16):8968-75.
9. Pettinger C, Holdsworth M, Gerber M. Meal patterns and cooking practices in Southern France and Central England. Public Health Nutr. 2006; 9(8):1020-6.
10. Tamers SL, Agurs-Collins T, Dodd KW, Nebeling L. US and France adult fruit and vegetable consumption patterns: an international comparison. Eur J Clin Nutr. 2009; 63(1):11-7.
11. Guevara-Cruz M, Torres N, Tovar AR, Tejero ME, Castellanos- Jankiewicz A, Del Bosque-Plata L. A Genetic Variant of the Capn10 Gene in Mexican Subjects with Dyslipidemia Is Associated with Increased Hdl-Cholesterol Concentrations after the Consumption of a Soy Protein and Soluble Fiber Dietary Portfolio. Nutr Hosp. 2014; 30(n03):671-7.
12. Goel N, Rao H, Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2009; 29(4):320-39.
13. Sanders TA. Fat and fatty acid intake and metabolic effects in the human body. Ann Nutr Metab. 2009; 55(1-3):162-72.
14. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009; 169(7):659-69.
15. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010; 91(3):535-46.
16. Elwood PC, Pickering JE, Givens DI, Gallacher JE. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids. 2010; 45(10):925-39.
17. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, Engberink MF, Willett WC, et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr. 2011; 93(1):158-71.
18. Goldbohm RA, Chorus AM, Galindo Garre F, Schouten LJ, van den Brandt PA. Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am J Clin Nutr. 2011; 93(3):615-27.
19. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003; 77(5):1146-55.
20. Kinosian B, Glick H, Preiss L, Puder KL. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Investig Med. 1995; 43(5):443-50.
21. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991; 325(6):373-81.
22. Assmann G, Schulte H, von Eckardstein A, Huang Y. High- density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 1996; 124 Suppl:S11-20.
23. Arribas L, Frias L, Creus G, Parejo J, Urzola C, Ashbaugh R, et al. Document of standardization of enteral nutrition access in adults. Nutr Hosp. 2014;30(1):1-14.
24. Legrand O, Simonin G, Perrot JY, Zittoun R, Marie JP. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood. 1998; 91(12):4480-8.
25. XVI Reunion de la Sociedad Espanola de Nutricion. Nutr Hosp. 2014; 30(s01):1-78.
26. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006; 114(1):82- 96.
27. Olivares S, Zacarías I, Gonzalez CG, Villalobos E. Proceso de formulación y validación de las guías alimentarias para la población chilena. Rev Chil Nutr. 2013; 40(3):262-8.
28. Roepke SK, Mausbach BT, Aschbacher K, Ziegler MG, Dimsdale JE, Mills PJ, et al. Personal mastery is associated with reduced sympathetic arousal in stressed Alzheimer caregivers. Am J Geriatr Psychiatry. 2008; 16(4):310-7.
29. Chee MW, Choo WC. Functional imaging of working memory after 24 hr of total sleep deprivation. J Neurosci. 2004; 24(19):4560-7.
30. de Oliveira Otto MC, Mozaffarian D, Kromhout D, Bertoni AG, Sibley CT, Jacobs DR, Jr., et al. Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2012; 96(2):397-404.
31. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, et al. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Annals of internal medicine. 2010; 153(12):790-9.
32. Alonso A, Nettleton JA, Ix JH, de Boer IH, Folsom AR, Bidulescu A, et al. Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis. Hypertension. 2010; 55(3):776-84.
33. Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens. 2003; 17(7):471-80.
34. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007; 92(6):2017- 29.
35. Choi HK, Willett WC, Stampfer MJ, Rimm E, Hu FB. Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med. 2005; 165(9):997-1003.
36. Fumeron F, Lamri A, Abi Khalil C, Jaziri R, Porchay-Balderelli I, Lantieri O, et al. Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a french prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes care. 2011; 34(4):813-7.
37. Ruidavets JB, Bongard V, Simon C, Dallongeville J, Ducimetiere P, Arveiler D, et al. Independent contribution of dairy products and calcium intake to blood pressure variations at a population level. J Hypertens. 2006;24(4):671-81.
38. Wang L, Manson JE, Buring JE, Lee IM, Sesso HD. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008; 51(4):1073-9.
39. Engberink MF, Hendriksen MA, Schouten EG, van Rooij FJ, Hofman A, Witteman JC, et al. Inverse association between dairy intake and hypertension: the Rotterdam Study. Am J Clin Nutr. 2009; 89(6):1877-83.
40. Lorenzen JK, Astrup A. Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet. Br J Nutr. 2011; 105(12):1823-31.
41. Crichton GE, Bryan J, Buckley J, Murphy KJ. Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues. Obes Rev. 2011; 12(5):e190-201.
42. Elwood PC, Givens DI, Beswick AD, Fehily AM, Pickering JE, Gallacher J. The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer. J Am Coll Nutr. 2008; 27(6):723S-34S.
43. Van Loan M. The role of dairy foods and dietary calcium in weight management. J Am Coll Nutr. 2009; 28 Suppl 1:120S-9S.
44. Christensen R, Lorenzen JK, Svith CR, Bartels EM, Melanson EL, Saris WH, et al. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev. 2009; 10(4):475-86.
45. Zemel MB, Sun X. Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans. J Nutr. 2008; 138(6):1047-52.
46. Pfeuffer M, Schrezenmeir J. Milk and the metabolic syndrome. Obes Rev. 2007; 8(2):109-18.
47. Warensjo E, Jansson JH, Berglund L, Boman K, Ahren B, Weinehall L, et al. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study. Br J Nutr. 2004; 91(4):635-42.
48. Sun X, Zemel MB. Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice. J Nutr. 2004; 134(11):3054-60.
49. Dunshea F OE, Ferrari JM, Gill H. Dairy proteins and the regulation of satiety and obesity. Aust J Exp Agric. 2007; 47:1-8.
50. Malpuech-Brugere C, Verboeket-van de Venne WP, Mensink RP, Arnal MA, Morio B, Brandolini M, et al. Effects of two conjugated linoleic Acid isomers on body fat mass in overweight humans. Obes Res. 2004; 12(4):591-8.
51. Huth PJ, DiRienzo DB, Miller GD. Major scientific advances with dairy foods in nutrition and health. J Dairy Sci. 2006; 89(4):1207-21.
52. Lock AL, Bauman DE. Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids. 2004; 39(12):1197-206.
53. Lawson RE, Moss AR, Givens DI. The role of dairy products in supplying conjugated linoleic acid to man's diet: a review. Nutr Res Rev. 2001; 14(1):153-72.
54. Kritchevsky D, Tepper SA, Wright S, Czarnecki SK, Wilson TA, Nicolosi RJ. Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. Lipids. 2004; 39(7):611-6.
55. Valeille K, Ferezou J, Amsler G, Quignard-Boulange A, Parquet M, Gripois D, et al. A cis-9,trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. Am J Physiol Heart Circ Physiol. 2005; 289(2):H652-9.
56. Lock AL, Horne CA, Bauman DE, Salter AM. Butter naturally enriched in conjugated linoleic acid and vaccenic acid alters tissue fatty acids and improves the plasma lipoprotein profile in cholesterol-fed hamsters. J Nutr. 2005; 135(8):1934-9.
57. Wahle KW, Heys SD, Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Progress In Lipid Research. 2004; 43(6):553-87.
58. Hassan Eftekhari M, Aliasghari F, Babaei-Beigi MA, Hasanzadeh J. Effect of conjugated linoleic acid and omega-3 fatty acid supplementation on inflammatory and oxidative stress markers in atherosclerotic patients. ARYA Atheroscler. 2013; 9(6):311-8.
59. Astrup A. Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies. Am J Clin Nutr. 2014; 99(5 Suppl):1235S-42S.
60. Larsson SC, Virtamo J, Wolk A. Dairy consumption and risk of stroke in Swedish women and men. Stroke. 2012; 43(7):1775-80.
61. Iso H, Stampfer MJ, Manson JE, Rexrode K, Hennekens CH, Colditz GA, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999; 30(9):1772-9.
62. Larsson SC, Mannisto S, Virtanen MJ, Kontto J, Albanes D, Virtamo J. Dairy foods and risk of stroke. Epidemiology. 2009; 20(3):355-60.
63. Sadeghi M, Khosravi-Boroujeni H, Sarrafzadegan N, Asgary S, Roohafza H, Gharipour M, et al. Cheese consumption in relation to cardiovascular risk factors among Iranian adults- IHHP Study. Nutr Res Pract. 2014; 8(3):336-41.
64. St-Onge MP, Farnworth ER, Jones PJ. Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. Am J Clin Nutr. 2000; 71(3):674-81.
65. Colquhoun DM, Somerset S, Irish K, Leontjew LM. Cheese added to a low fat diet does not affect serum lipids. Asia Pacific Journal Of Clinical Nutrition. 2003; 12 Suppl:S65.
66. Tholstrup T, Hoy CE, Andersen LN, Christensen RD, Sandstrom B. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently?. J Am Coll Nutr. 2004; 23(2):169- 76.
67. Hostmark AT, Tomten SE. The Oslo health study: cheese intake was negatively associated with the metabolic syndrome. J Am Coll Nutr. 2011; 30(3):182-90.
68. Tavani A, Gallus S, Negri E, La Vecchia C. Milk, dairy products, and coronary heart disease. J Epidemiol Community Health. 2002; 56(6):471-2.
69. Biong AS, Muller H, Seljeflot I, Veierod MB, Pedersen JI. A comparison of the effects of cheese and butter on serum lipids, haemostatic variables and homocysteine. Br J Nutr. 2004; 92(5):791-7.
70. Nestel PJ, Chronopulos A, Cehun M. Dairy fat in cheese raises LDL cholesterol less than that in butter in mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 2005; 59(9):1059-63.
71. Hjerpsted J, Leedo E, Tholstrup T. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am J Clin Nutr. 2011; 94(6):1479-84.
72. Moss M, Freed D. The cow and the coronary: epidemiology, biochemistry and immunology. Int J Cardiol. 2003; 87(2- 3):203-16.
73. Kabagambe EK, Baylin A, Siles X, Campos H. Individual saturated fatty acids and nonfatal acute myocardial infarction in Costa Rica. Eur J Clin Nutr. 2003; 57(11):1447-57.
74. Warensjo E, Jansson JH, Cederholm T, Boman K, Eliasson M, Hallmans G, et al. Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study. Am J Clin Nutr. 2010; 92(1):194-202.
75. Ralston RA, Lee JH, Truby H, Palermo CE, Walker KZ. A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J Hum Hypertens. 2012; 26(1):3-13.
76. EL-Sheikh MM E-SM, Youssef YB, Shahein NM, Abd Rabou NS. Effect of ripening conditions on the properties of blue cheese produced from cow's and goat's milk. J Am Sci. 2011; 7(1):485-90.
77. Nielsen KF, Dalsgaard PW, Smedsgaard J, Larsen TO. Andrastins A-D, Penicillium roqueforti Metabolites consistently produced in blue-mold-ripened cheese. J Agric Food Chem. 2005; 53(8): 2908-13.
78. Aninat C, Hayashi Y, Andre F, Delaforge M. Molecular requirements for inhibition of cytochrome p450 activities by roquefortine. Chem. Res Toxicol. 2001; 14(9):1259-65.
79. Torres-Llanez MJ, Gonzalez-Cordova AF, Hernandez-Mendoza A, Garcia HS, Vallejo-Cordoba B. Angiotensin-converting enzyme inhibitory activity in Mexican Fresco cheese. J Dairy Sci. 2011; 94(8):3794-800.
80. Phelan M, Kerins D. The potential role of milk-derived peptides in cardiovascular disease. Food Funct. 2011; 2(3-4):153- 67.
81. Panagiotakos DB, Pitsavos CH, Zampelas AD, Chrysohoou CA, Stefanadis CI. Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults: the ATTICA study. J Am Coll Nutr. 2010; 29(4):357-64.
82. Louie JC, Flood VM, Hector DJ, Rangan AM, Gill TP. Dairy consumption and overweight and obesity: a systematic review of prospective cohort studies. Obes Rev. 2011; 12(7):e582-92.
83. Shin H, Yoon YS, Lee Y, Kim CI, Oh SW. Dairy product intake is inversely associated with metabolic syndrome in Korean adults: Anseong and Ansan cohort of the Korean Genome and Epidemiology Study. J Korean Med Sci. 2013; 28(10):1482-8.
84. Kratz M, Baars T, Guyenet S. The relationship between high- fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Clin Nutr. 2013; 52(1):1-24.
85. Abargouei AS, Janghorbani M, Salehi-Marzijarani M, Esmaillzadeh A. Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obes (Lond). 2012; 36(12):1485-93.
86. Samara A, Herbeth B, Ndiaye NC, Fumeron F, Billod S, Siest G, et al. Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5 years in the STANISLAS study. Nutrition. 2013; 29(3):519-24.
87. O'Connor LM, Lentjes MA, Luben RN, Khaw KT, Wareham NJ, Forouhi NG. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia. 2014; 57(5):909-17.
88. Tong X, Dong JY, Wu ZW, Li W, Qin LQ. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr. 2011; 65(9):1027-31.
89. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products and the risk of type 2 diabetes: a systematic review and dose- response meta-analysis of cohort studies. Am J Clin Nutr. 2013; 98(4):1066-83.
90. Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, et al. Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PloS one. 2013; 8(9):e73965.
91. Struijk EA, Heraclides A, Witte DR, Soedamah-Muthu SS, Geleijnse JM, Toft U, et al. Dairy product intake in relation to glucose regulation indices and risk of type 2 diabetes. Nutr Metab Cardiovasc Dis. 2013; 23(9):822-8.
92. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes care. 2005; 28(12):2823-31.
93. Belin RJ, He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res. 2007; 20(2):107-29.
94. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000; 30(6):298- 307.
95. Beulens JW, van der AD, Grobbee DE, Sluijs I, Spijkerman AM, van der Schouw YT. Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes care. 2010; 33(8):1699-705.
96. Shea MK, Dallal GE, Dawson-Hughes B, Ordovas JM, O'Donnell CJ, Gundberg CM, et al. Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr. 2008; 88(2):356-63.
97. Kirii K, Iso H, Date C, Fukui M, Tamakoshi A. Magnesium intake and risk of self-reported type 2 diabetes among Japanese. J Am Coll Nutr. 2010; 29(2):99-106.
98. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes care. 2004; 27(1):134- 40.
99. Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes care. 2011; 34(9):2116-22.
100. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci. 2011; 94(7):3288-94.
101. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari- Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012; 28(5):539- 43.
102. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006; 100(6):1171-85.
103. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr. 2005; 82(3):523-30.
104. Mennen LI LL, Feskens EJM, Novak M, Lepinay P, Balkau B. Possible protective effect of bread and dairy products on the risk of metabolic syndrome. Nutr Res. 2000; 20:335-47.
105. Pereira MA, Jacobs DR, Jr., Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. Jama. 2002; 287(16):2081-9.
106. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation. 2008; 117(6):754-61.
107. Altorf-van der Kuil W, Engberink MF, Brink EJ, van Baak MA, Bakker SJ, Navis G, et al. Dietary protein and blood pressure: a systematic review. PloS one. 2010; 5(8):e12102.
108. Kris-Etherton PM, Grieger JA, Hilpert KF, West SG. Milk products, dietary patterns and blood pressure management. J Am Coll Nutr. 2009; 28 Suppl 1:103S-19S.
109. McGrane MM, Essery E, Obbagy J, Lyon J, Macneil P, Spahn J, et al. Dairy Consumption, Blood Pressure, and Risk of Hypertension: An Evidence-Based Review of Recent Literature. Curr Cardiovasc Risk Rep. 2011; 5(4):287-98.
110. Soedamah-Muthu SS, Verberne LD, Ding EL, Engberink MF, Geleijnse JM. Dairy consumption and incidence of hypertension: a dose-response meta-analysis of prospective cohort studies. Hypertension. 2012; 60(5):1131-7.
111. Alonso A, Steffen LM, Folsom AR. Dairy intake and changes in blood pressure over 9 years: the ARIC study. Eur J Clin Nutr. 2009; 63(10):1272-5.
112. Dauchet L, Kesse-Guyot E, Czernichow S, Bertrais S, Estaquio C, Peneau S, et al. Dietary patterns and blood pressure change over 5-y follow-up in the SU.VI.MAX cohort. Am J Clin Nutr. 2007; 85(6):1650-6.
113. Snijder MB, van Dam RM, Stehouwer CD, Hiddink GJ, Heine RJ, Dekker JM. A prospective study of dairy consumption in relation to changes in metabolic risk factors: the Hoorn Study. Obesity (Silver Spring). 2008; 16(3):706-9.
114. Engberink MF, Geleijnse JM, de Jong N, Smit HA, Kok FJ, Verschuren WM. Dairy intake, blood pressure, and incident hypertension in a general Dutch population. J Nutr. 2009; 139(3):582-7.
115. Heraclides A, Mishra GD, Hardy RJ, Geleijnse JM, Black S, Prynne CJ, et al. Dairy intake, blood pressure and incident hypertension in a general British population: the 1946 birth cohort. Eur J Clin Nutr. 2012; 51(5):583-91.
116. Steffen LM, Kroenke CH, Yu X, Pereira MA, Slattery ML, Van Horn L, et al. Associations of plant food, dairy product, and meat intakes with 15-y incidence of elevated blood pressure in young black and white adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2005; 82(6):1169-77; quiz 363-4.
117. Nilsen R, Pripp AH, Hostmark AT, Haug A, Skeie S. Short communication: Is consumption of a cheese rich in angiotensin-converting enzyme-inhibiting peptides, such as the Norwegian cheese Gamalost, associated with reduced blood pressure?. J Dairy Sci. 2014; 97(5):2662-8.